DE10299023I1 - Antineoplastisch wirkender und den Antineoplastischen effekt Verstaerkender Wirkstoff - Google Patents

Antineoplastisch wirkender und den Antineoplastischen effekt Verstaerkender Wirkstoff

Info

Publication number
DE10299023I1
DE10299023I1 DE2002199023 DE10299023C DE10299023I1 DE 10299023 I1 DE10299023 I1 DE 10299023I1 DE 2002199023 DE2002199023 DE 2002199023 DE 10299023 C DE10299023 C DE 10299023C DE 10299023 I1 DE10299023 I1 DE 10299023I1
Authority
DE
Germany
Prior art keywords
antineoplastic effect
antineoplastic
potentiating
effect
enhances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE2002199023
Other languages
English (en)
Other versions
DE10299023I2 (de
Inventor
Junji Uchida
Hiroyuki Okabe
Teiji Takechi
Setsuo Takeda
Yuji Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17034249&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE10299023(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE10299023I1 publication Critical patent/DE10299023I1/de
Publication of DE10299023I2 publication Critical patent/DE10299023I2/de
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE10299023C 1990-09-07 1991-09-05 Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff Active DE10299023I2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23871990 1990-09-07
PCT/JP1991/001187 WO1992004028A1 (fr) 1990-09-07 1991-09-05 Potentialisateur d'effets antineoplasique et agent antineoplasique

Publications (2)

Publication Number Publication Date
DE10299023I1 true DE10299023I1 (de) 2003-06-05
DE10299023I2 DE10299023I2 (de) 2010-05-06

Family

ID=17034249

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10299023C Active DE10299023I2 (de) 1990-09-07 1991-09-05 Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
DE69121551T Expired - Lifetime DE69121551T2 (de) 1990-09-07 1991-09-05 Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69121551T Expired - Lifetime DE69121551T2 (de) 1990-09-07 1991-09-05 Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff

Country Status (14)

Country Link
EP (1) EP0500953B1 (de)
JP (1) JP2557303B2 (de)
KR (1) KR0146952B1 (de)
AT (1) ATE141506T1 (de)
AU (1) AU644684B2 (de)
CA (1) CA2071819A1 (de)
DE (2) DE10299023I2 (de)
DK (1) DK0500953T3 (de)
ES (1) ES2091941T3 (de)
GR (1) GR3021003T3 (de)
HU (1) HU211739A9 (de)
LU (1) LU90791I2 (de)
NL (1) NL300041I2 (de)
WO (1) WO1992004028A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05310573A (ja) * 1992-05-01 1993-11-22 Dotsuto:Kk リウマチ治療薬
US5643191A (en) * 1995-01-26 1997-07-01 Sorin Biomedical Inc. Cardioplegia delivery system and method for converting from warm cardioplegia to cold cardioplegia
US5702358A (en) * 1995-02-23 1997-12-30 Sorin Biomedical Inc. Cardioplegia delivery apparatus and method of use
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
US6538001B1 (en) * 1998-10-12 2003-03-25 Nikolai Borisovich Leonidov Crystalline modification of 5-fluoro-1-(tetrahydro-2-furyl) uracil and complex compounds based thereon, producing antineoplastic effect
RU2334517C2 (ru) * 2003-03-14 2008-09-27 Тайхо Фармасьютикал Ко., Лтд. Средство, потенцирующее противоопухолевый эффект, и противоопухолевое средство
TWI468188B (zh) 2008-01-30 2015-01-11 Univ Tokushima Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
WO2009139085A1 (ja) 2008-05-12 2009-11-19 静岡県 抗腫瘍剤、キット及び癌治療方法
KR102258514B1 (ko) * 2019-09-23 2021-05-31 연세대학교 산학협력단 신규한 다층형 좌약 제제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5953885B2 (ja) * 1978-02-10 1984-12-27 大鵬薬品工業株式会社 抗腫瘍剤組成物
GB2016921B (en) * 1978-03-27 1982-08-18 Taiho Pharmaceutical Co Ltd Anti cancer compositions containing uracil derivatives
JPS5780319A (en) * 1980-11-06 1982-05-19 Taiho Yakuhin Kogyo Kk Anti-tumor agent having reduced toxicity
JPS5838210A (ja) * 1981-08-31 1983-03-05 Taiho Yakuhin Kogyo Kk 直腸投与用製剤

Also Published As

Publication number Publication date
EP0500953A4 (en) 1993-04-21
WO1992004028A1 (fr) 1992-03-19
EP0500953B1 (de) 1996-08-21
KR0146952B1 (ko) 1998-08-17
JP2557303B2 (ja) 1996-11-27
DE10299023I2 (de) 2010-05-06
ATE141506T1 (de) 1996-09-15
KR927002224A (ko) 1992-09-03
CA2071819A1 (en) 1992-03-08
DK0500953T3 (da) 1997-01-06
DE69121551D1 (de) 1996-09-26
GR3021003T3 (en) 1996-12-31
DE69121551T2 (de) 1997-01-02
NL300041I1 (nl) 2001-06-01
AU8447991A (en) 1992-03-30
HU211739A9 (en) 1995-12-28
LU90791I2 (fr) 2001-10-08
AU644684B2 (en) 1993-12-16
EP0500953A1 (de) 1992-09-02
NL300041I2 (nl) 2002-02-01
ES2091941T3 (es) 1996-11-16

Similar Documents

Publication Publication Date Title
NL970006I2 (nl) Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.
ATE136542T1 (de) Pyrimidine und deren pharmazeutisch brauchbare salze und deren verwendung als arzneimittel
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
MX9707453A (es) Derivados de quinazolina.
DE69318031D1 (de) Ematiomerenreine beta-d-dioxolane nucleoside mit selektiver antihepatitis b-virus wirkung
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
KR910019618A (ko) 발기부전증 치료용 제약 조성물
DE69322251T2 (de) Medizinische zusammensetzung
DE10299023I1 (de) Antineoplastisch wirkender und den Antineoplastischen effekt Verstaerkender Wirkstoff
DK0476066T3 (da) Antiviralt præparat indeholdende 3-azido-2,3-dideoxy-5-methylcytidin
MY104521A (en) Treatment of depression.
KR910015300A (ko) 부스피론 : 수면 무호흡증의 치료용도
DE69019404D1 (de) Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
ES2052670T3 (es) Utilizacion de derivados de 2-pirimidinil-1-piperazina.
FR2534809B1 (fr) Association medicamenteuse, renfermant a titre de principes actifs, un analgesique central et la vitamine b 12 ou un derive de celle-ci
DE3867251D1 (de) Medikamente fuer die behandlung von rheumatoider arthritis.
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
KR890007737A (ko) 진토작용을 하는 약제
KR900016130A (ko) 2-피리딜메틸티오 유도체 및 궤양 치료제
PT728002E (pt) Utilizacao de derivados de 2-amino purina para o tratamento e profilaxia da infeccao pelo virus de herpes 7 humano
KR910018026A (ko) α-페닐-α피리딜알칸산 유도체를 함유하는 배뇨장애증상 치료제
DE69228945D1 (de) Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung